Synonyms: ASO-10-27 | Ionis-SMNrx | ISIS 396443 | ISIS-SMNRx | ISIS396443 | Spinraza®
nusinersen is an approved drug (FDA (2016), EMA (2017))
Compound class:
Synthetic organic
Comment: Nusinersen (ISIS 396443) is an antisense oligo(ribo)nucleotide (ASO) which induces survival motor neuron (SMN) protein expression from SMN2 genes with the exon 7-skipping mutation [7].
Nusinersen was initially available for use as a designated orphan drug (by the US FDA and EMA), and was the first drug to be fully approved for the treatment of spinal muscular atrophy (SMA). The sequence contains 2'-O-(2-methoxyethyl) (2'-MOE)-oligoribonucleotides to reduce nuclease degradation and enhance binding affinity towards the complementary RNA. The full sequence is [2'-O-(2-methoxyethyl)](3'-5')(P-thio)(mU-mC-A-mC-mU-mU-mU-mC-A-mU-A-A-mU-G-mC-mU-G-G) as detailed in the INN record for the agent. A full structural rendering using SMILES from Chemspider is available here (CSID:34983394). The sequence for nusinersen is claimed in patent WO2010148249A1 as SEQ ID NO: 1 [1]. |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2016), EMA (2017)) |
International Nonproprietary Names ![]() |
|
INN number | INN |
10003 | nusinersen |
Synonyms ![]() |
ASO-10-27 | Ionis-SMNrx | ISIS 396443 | ISIS-SMNRx | ISIS396443 | Spinraza® |
Database Links ![]() |
|
CAS Registry No. | 1258984-36-9 (source: WHO INN record) |
GtoPdb PubChem SID | 328083518 |
PubChem CID | 124037382 |
Search Google for chemical match using the InChIKey | WWFDJIVIDXJAQR-FFWSQMGZSA-N |
Search Google for chemicals with the same backbone | WWFDJIVIDXJAQR |
Search PubMed clinical trials | nusinersen |
Search PubMed titles | nusinersen |
Search PubMed titles/abstracts | nusinersen |
UniChem Compound Search for chemical match using the InChIKey | WWFDJIVIDXJAQR-FFWSQMGZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WWFDJIVIDXJAQR-FFWSQMGZSA-N |